Kelly Baden
Kelly Baden is the vice president for public policy at the Guttmacher Institute. Prior to this, she served as the senior vice president of strategic initiatives at State Innovation Exchange.
Claims from Kelly Baden
Kelly BadenThe argument for withdrawing mifepristone's FDA approval is "a baseless case that could dramatically reduce nationwide access to mifepristone."Dec 13, 2023
Controversy:Will Mifepristone Be Banned in the US?
Kelly Baden"[T]he Supreme Court has only one reasonable option—honor the FDA approval of mifepristone."Dec 13, 2023
Controversy:Will Mifepristone Be Banned in the US?